Does FENOFIBRATE Cause Hepatic cytolysis? 52 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 52 reports of Hepatic cytolysis have been filed in association with FENOFIBRATE (Fenofibrate). This represents 0.9% of all adverse event reports for FENOFIBRATE.
52
Reports of Hepatic cytolysis with FENOFIBRATE
0.9%
of all FENOFIBRATE reports
4
Deaths
31
Hospitalizations
How Dangerous Is Hepatic cytolysis From FENOFIBRATE?
Of the 52 reports, 4 (7.7%) resulted in death, 31 (59.6%) required hospitalization, and 13 (25.0%) were considered life-threatening.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for FENOFIBRATE. However, 52 reports have been filed with the FAERS database.
What Other Side Effects Does FENOFIBRATE Cause?
Myalgia (411)
Dyspnoea (373)
Fatigue (365)
Asthenia (356)
Dizziness (356)
Fall (354)
Drug ineffective (326)
Pruritus (325)
Nausea (311)
Diarrhoea (310)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which FENOFIBRATE Alternatives Have Lower Hepatic cytolysis Risk?
FENOFIBRATE vs FENOFIBRIC ACID
FENOFIBRATE vs FENOTEROL
FENOFIBRATE vs FENOTEROL HYDROBROMIDE
FENOFIBRATE vs FENOTEROL HYDROBROMIDE\IPRATROPIUM
FENOFIBRATE vs FENTANYL